Daily non-political popular news in brief.

Link uncovered between variation in humans with extreme body mass and abnormal splicing

12-20-2007 · EurekAlert!

Today researchers report new insights into how genetic variation may create phenotypic differences between individuals. This study, which investigates the influence of mutations associated with obesity on the mechanism of splicing, is published online in Genome Research.

Keywords: link, uncovered, variation, humans, extreme, body, mass, abnormal, splicing, human

« Previous | Next »

Similar news on "Link uncovered between variation in humans with extreme body mass and abnormal splicing":

Run amok enzyme causes same problems in both humans and fruit flies
12-18-2006 · EurekAlert!
An enzyme found at elevated levels in several human cancers has been linked to abnormal tumor growth in fruit flies, a discovery that provides a new model for understanding the link between stem cell biology and cancer, according to researchers at the University of Oregon.
Similar news · Read more »
Growth hormone is not the anti-aging bullet for healthy adults
01-15-2007 · EurekAlert!
A review of published data on use of human growth hormone by healthy elderly people found that the synthetic hormone was associated with small changes in body composition but not in body weight or other clinically important outcomes. Further, people who took GH had increased rates of unhealthy side effects such as soft tissue swelling, joint pain, carpal tunnel syndrome, and, in men, abnormal breast development and were also somewhat more likely to develop diabetes.
Similar news · Read more »
'Extreme' teenagers
10-03-2007 · EurekAlert!
Adolescents have grown taller and put on weight over the last 30 years, but the problem of underweight teens may be worse, a study in the online open access journal BMC Public Health suggests. An analysis of the height, weight and body-mass index of teenagers during 1966-1969 and 1995-1997 in Norway demonstrates a shift towards taller and heavier teenagers, but also hints that there are more underweight adolescents.
Similar news · Read more »
Pediatrics study shows no link between juice and children's weight
10-27-2006 · EurekAlert!
Research published in the October issue of Pediatrics evaluated data from a national sample of preschool children and determined that consumption of 100 percent juice was not associated with body mass index (an indicator of overweight) among preschoolers.
Similar news · Read more »
A longer-living, healthier mouse that could hold clues to human aging
10-22-2007 · EurekAlert!
A study by scientists at UCL shows that mice lacking the insulin receptor substrate-1 are more resistant to aging than normal mice. The research adds to a growing body of work showing the importance of insulin signaling pathways as an aging mechanism in mammals -- and potentially humans.
Similar news · Read more »
Genetic variation: We're more different than we thought
11-22-2006 · EurekAlert!
New research shows that at least 10 percent of genes in the human population can vary in the number of copies of DNA sequences they contain -- a finding that alters current thinking that the DNA of any two humans is 99.9 percent similar in content and identity. This discovery of genetic variation is expected to change the way scientists think about genetic diseases and evolution.
Similar news · Read more »
Possible genetic link to schizophrenia identified
02-08-2007 · EurekAlert!
Several neurological and psychiatric disorders, including schizophrenia, are associated with changes in the brain that affect nerves that communicate with each other using dopamine. One protein that is crucial for dopamine-mediated neuronal communication in animals is DARPP-32. Now, researchers have shown that the gene that encodes DARPP-32 in humans exhibits genetic variation and that one particular variant is associated with increased performance in a number of cognitive tests and with an increased risk of schizophrenia.
Similar news · Read more »
Advance in understanding of blood pressure gene could lead to new treatments
02-04-2007 · EurekAlert!
Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer. In a paper published online today in Nature Medicine, the team, led by Professor Patrick Vallance and Dr James Leiper, UCL Department of Medicine, reveal the role of the human gene dimethylarginine dimethylaminohydrolase (DDAH), showing that loss of DDAH activity disrupts nitric oxide (NO) production. NO is critical in the regulation of blood pressure, nervous system functions and the immune system. The role of DDAH is to break down modified amino acids (Asymmetric dimethylarginine (ADMA) and monomethyl arginine (L-NMMA)) that are produced by the body and have been shown to inhibit NO synthase. These molecules accumulate in various disease states including diabetes, renal failure and pulmonary and systemic hypertension, and their concentration in plasma (the fluid component of blood) is strongly predicative of cardiovascular disease and death. In a healthy human body, the majority of ADMA is eliminated through active metabolism by DDAH. Scientists have hypothesised that if DDAH function is impaired, NO production is reduced, and that this could be an important feature of increased cardiovascular risk. To examine this pathway in more detail, the researchers deleted the DDAH gene in mice. These mice went on to develop hypertension, or high blood pressure. They also designed specific inhibitors (small molecules) which bind to the active site of human DDAH. These small molecule inhibitors also induced hypertension in mice, confirming the importance of DDAH in the regulation of blood pressure. Dr Leiper, UCL Medicine, said: “These genetic and chemical approaches to disrupt DDAH showed remarkably consistent results, and provide compelling evidence that loss of DDAH function increases the concentration of ADMA and thereby disrupts vascular NO signalling. “There has been considerable scientific interest in this pathway and the role of ADMA as a novel risk factor, but so far there's been little evidence to support the idea that it's a cause of disease, rather than just a marker. Genes and their pathways are crucial to our understanding of cardiovascular disease and a better understanding of DDAH-1 could lead to important new treatments. “It could help us to establish if genetic variation predisposes certain people to these diseases, or whether environmental factors exert some of their effects through modulation of DDAH activity. “Our research also shows that this pathway could be harnessed therapeutically to limit production of NO in certain situations where too much nitric oxide is a bad thing; for example, hypotension and septic shock. These are some of the biggest problems in intensive care medicine and there is a huge unmet need for drug treatments.” The study, which was carried out at UCL's Rayne Institute, was funded by grants from the British Heart Foundation, the Wellcome Trust and the Medical Research Council. Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation, said: "The unexpected finding in the 1980s that a simple gas, nitric oxide (NO), is made by cells in the blood vessel wall and is a powerful control of blood vessel relaxation led to the award of the Nobel Prize in 1998 to its discoverers. "More recently, there has been increasing evidence that impairment of NO production is likely to be an important factor in the development of heart and circulatory disease, but the mechanisms responsible are not fully understood. "This study suggests for the first time that the loss of the activity of the enzyme DDAH-1 leads to reduced NO production and may cause heart and circulatory disease. These findings are likely to be important in the search for new ways to optimise the health of our blood vessels." ### Notes for Editors 1. For more information, please contact Ruth Metcalfe in the UCL Media Relations Office on tel: +44 (0)20 7679 9739, mobile: +44 (0)7990 675 947, out of hours: +44 (0)7917 271 364, e-mail: r.metcalfe@ucl.ac.uk2. 'Disruption of methylarginine metabolism impairs vascular homeostasis' is published in the February issue of the journal Nature Medicine. Advance online publication is embargoed to 18.00 GMT (13.00 US Eastern) Sunday 4 February 2007. Journalists can obtain copies of the paper by contacting the UCL Media Relations Office.3. The study was funded by the British Heart Foundation, the Wellcome Trust and the Medical Research Council. About UCL Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government's most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence. UCL is the fourth-ranked UK university in the 2006 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Mahatma Gandhi (Laws 1889, Indian political and spiritual leader); Jonathan Dimbleby (Philosophy 1969, writer and television presenter); Junichiro Koizumi (Economics 1969, Prime Minister of Japan); Lord Woolf (Laws 1954, Lord Chief Justice of England & Wales); Alexander Graham Bell (Phonetics 1860s, inventor of the telephone), and members of the band Coldplay.
Similar news · Read more »
New findings solve human origins mystery
10-09-2007 · EurekAlert!
New research from Harvard University's Museum of Comparative Zoology and from the Cedars Sinai Institute for Spinal Disorders reveals evidence of the emergence of the upright human body plan over 15 million years earlier than most experts have believed. More dramatically, the study confirms preliminary evidence that many early hominoid apes were most likely upright bipedal walkers sharing the basic body form of modern humans. The study appears in PLoS ONE on Oct. 10.
Similar news · Read more »
From a lowly yeast, researchers divine a clue to human disease
12-07-2006 · EurekAlert!
Working with a common form of brewer's yeast, University of Wisconsin-Madison researchers have uncovered novel functions of a key protein that allow it to act as a master regulatory switch -- a control that determines gene activity and that, when malfunctioning in humans, may contribute to serious neurological disorders.
Similar news · Read more »